Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Total Liabilities: 2011-2024

Historic Total Liabilities for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $22.2 million.

  • Niagen Bioscience's Total Liabilities rose 23.97% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 23.97%. This contributed to the annual value of $22.2 million for FY2024, which is 16.31% down from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Total Liabilities is $22.2 million, which was down 16.31% from $26.5 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Total Liabilities ranged from a high of $26.5 million in FY2023 and a low of $21.9 million during FY2020.
  • In the last 3 years, Niagen Bioscience's Total Liabilities had a median value of $25.4 million in 2022 and averaged $24.7 million.
  • Per our database at Business Quant, Niagen Bioscience's Total Liabilities grew by 19.05% in 2021 and then declined by 16.31% in 2024.
  • Over the past 5 years, Niagen Bioscience's Total Liabilities (Yearly) stood at $21.9 million in 2020, then climbed by 19.05% to $26.1 million in 2021, then dropped by 2.79% to $25.4 million in 2022, then increased by 4.42% to $26.5 million in 2023, then dropped by 16.31% to $22.2 million in 2024.